Glyceraldehyde-3-phosphate dehydrogenase - Revision history

Bernadett at 11:40, 10 March 2015

2015-03-10T11:40:44Z

2015-03-10T11:40:29Z

2015-03-10T11:40:11Z

2015-03-10T11:39:57Z

2007-09-28T06:14:18Z

2007-08-31T11:49:45Z

2007-07-25T07:56:21Z

2007-07-23T10:59:49Z

2007-07-23T10:59:06Z

2007-07-23T10:58:13Z

@@ Line 1: / Line 1: @@
 {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;"
 ! {infobox header}| '''{{PAGENAME}}'''
 |-
 | Substrate peptide name

← Older revision		Revision as of 11:40, 10 March 2015
Line 1:		Line 1:
		+	{\| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;"
		+	! {infobox header}\| '''{{PAGENAME}}'''
		+	\|-
	\| align="center" colspan="2" bgcolor="#ffffff" \| [[Image:GAPDH.JPG\|200px\|{{PAGENAME}}]]		\| align="center" colspan="2" bgcolor="#ffffff" \| [[Image:GAPDH.JPG\|200px\|{{PAGENAME}}]]
	\|-		\|-

← Older revision		Revision as of 11:40, 10 March 2015
Line 1:		Line 1:
−	~~{\| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;"~~
−	~~! {infobox header}\| '''{{PAGENAME}}'''~~
−	\|-
	\| align="center" colspan="2" bgcolor="#ffffff" \| [[Image:GAPDH.JPG\|200px\|{{PAGENAME}}]]		\| align="center" colspan="2" bgcolor="#ffffff" \| [[Image:GAPDH.JPG\|200px\|{{PAGENAME}}]]
	\|-		\|-

@@ Line 1: / Line 1: @@
 {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;"
-! {{infobox header}}| '''{{PAGENAME}}'''
+! {infobox header}| '''{{PAGENAME}}'''
 |-
 | align="center" colspan="2" bgcolor="#ffffff" | [[Image:GAPDH.JPG|200px|{{PAGENAME}}]]
@@ Line 53: / Line 53: @@
 |-
-| {{infobox header}} |
+| {infobox header} |
 |-
 |}
 [[Category:Tissue transglutaminase|*]]

@@ Line 21: / Line 21: @@
 |-
 | Swissprot ID
-| [http://au.expasy.org/uniprot/P08865 P08865]
+| [http://au.expasy.org/uniprot/P46406 P46406]
 |-
 | Reactive glutamines

@@ Line 2: / Line 2: @@
 ! {{infobox header}}| '''{{PAGENAME}}'''
 |-
-| align="center" colspan="2" bgcolor="#ffffff" | [[Image:{{PAGENAME}}.png|200px|{{PAGENAME}}]]
+| align="center" colspan="2" bgcolor="#ffffff" | [[Image:GAPDH.JPG|200px|{{PAGENAME}}]]
 |-
 | Substrate peptide name
@@ Line 27: / Line 27: @@
 |-
 | Reactive lysines
-| [[K191, K268, K331 (GAPDH)|K191, K268, K331]]
+| [[TG2 reactive residues (GAPDH)|K191, K268, K331]]
 |-
 | Substrate sequence

@@ Line 41: / Line 41: @@
 |-
 | Surface accessibility
-| [http://gibk21.bse.kyutech.ac.jp/asaview/all/2btfA.pdf ASAView] pdf
+| [http://gibk21.bse.kyutech.ac.jp/netasa/asaview/tmp/120891ext.pdf ASAView] pdf
 |-
 | Disorder prediction

@@ Line 50: / Line 50: @@
 |-
 | Notes
+| It's activity decreases upon crosslinking by TG2
 |-
 | {{infobox header}} |

@@ Line 30: / Line 30: @@
 |-
 | Substrate sequence
-| DSPSGKLWRGG
+| DSPSG''K''LWRGG
-SEGPLKGILGY
+SEGPL''K''GILGY
-AHMASKE
+AHMAS''K''E
 |-